These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3323254)

  • 21. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study.
    Olsen ML; O'Connor S; Arnett FC; Rosenbaum D; Grotta JC; Warner NB
    Am J Med; 1991 Apr; 90(4):479-88. PubMed ID: 1901447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of rheumatic diseases: tests and traps.
    Schmidt MC
    Hosp Pract (Off Ed); 1984 Sep; 19(9):82E-82G, 82K, 82O passim. PubMed ID: 6432827
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical utility of common serum rheumatologic tests.
    Lane SK; Gravel JW
    Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic tests in the diagnosis of rheumatic diseases. Part I.
    McDuffie FC; Bunch TW
    Bull Rheum Dis; 1976-1977; 27(5):900-5. PubMed ID: 65195
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of Anti-Extractable Nuclear Antigens in Patients with Systemic Rheumatic Disease via Fluorescence Enzyme Immunoassay and Its Clinical Utility.
    Oh J; Park Y; Lee KA; Kim HS
    Yonsei Med J; 2020 Jan; 61(1):73-78. PubMed ID: 31887802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
    Ordeig J; Guardia J
    J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidden anti-nuclear antibodies in rheumatic diseases.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1980 Feb; 39(2):538-43. PubMed ID: 6993073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies of systemic rheumatic diseases in the healthy elderly.
    Ruffatti A; Rossi L; Calligaro A; Del Ross T; Lagni M; Marson P; Todesco S
    Gerontology; 1990; 36(2):104-11. PubMed ID: 2376330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antinuclear antibodies in diagnosis of rheumatic diseases (author's transl)].
    Helmke K; Scheuermann R; Boeder T; Oppermann M; Teuber J; Federlin K
    Klin Wochenschr; 1981 Mar; 59(6):287-96. PubMed ID: 7015004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Evaluation of ELISA and Chemiluminescent Assays as Alternative Screening Tests to Indirect Immunofluorescence for the Detection of Antibodies to Cellular Antigens.
    de Almeida Brito F; Maria Elói Santos S; Aparecida Ferreira G; Pedrosa W; Gradisse J; Cristina Costa L; Pretti Figueiredo Neves S
    Am J Clin Pathol; 2016 Mar; 145(3):323-31. PubMed ID: 27124914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current use and interpretation of rheumatologic tests.
    Moder KG; Mason TG
    Adolesc Med; 1998 Feb; 9(1):25-34, v. PubMed ID: 10961249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging technologies in autoantibody testing for rheumatic diseases.
    Olsen NJ; Choi MY; Fritzler MJ
    Arthritis Res Ther; 2017 Jul; 19(1):172. PubMed ID: 28738887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection and differentiation of autoantibodies to extractable nuclear antigens with immunoenzyme tests].
    Horeschi G; Morenz J; Struy H
    Allerg Immunol (Leipz); 1987; 33(4):203-13. PubMed ID: 2449813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current status of immunological diagnosis in rheumatic diseases].
    Furcoi I
    Rev Med Chir Soc Med Nat Iasi; 1977; 81(1):139-40. PubMed ID: 68533
    [No Abstract]   [Full Text] [Related]  

  • 38. Appropriate laboratory testing in rheumatic diseases.
    Metzger AL; Morris RI
    Lippincotts Prim Care Pract; 1998; 2(1):52-65. PubMed ID: 9451199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating antinuclear antibody and rheumatoid factor in coal pneumoconiosis.
    Soutar CA; Turner-Warwick M; Parkes WR
    Br Med J; 1974 Jul; 3(5924):145-7. PubMed ID: 4602134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avoiding laboratory test misinterpretation in geriatric rheumatology.
    Wernick R
    Geriatrics; 1989 Feb; 44(2):61-3, 67-8, 73-8 passim. PubMed ID: 2644158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.